Skip to main content
. Author manuscript; available in PMC: 2015 Jan 30.
Published in final edited form as: J Nutr Health Aging. 2011 Aug;15(8):725–730. doi: 10.1007/s12603-011-0058-9

Table 2.

Main endogenous and exogenous factors to be considered as inclusion/exclusion criteria for Phase II trials on sarcopenia.

Endogenous Exogenous
Age Physical activity level
Gender Smoking status
Race/Ethnicity Nutritional status
Inflammation Alcohol consumption
Hormonal modifications Medications use
Baseline body composition Social support*
Clinical conditions (e.g., AIDS, anemia, arthritis, cancer, chronic obstructive pulmonary disease, cognitive impairment*, congestive heart failure, depression diabetes, kidney disease, metabolic syndrome, neurological diseases [stroke, spinal compression], Parkinson's disease)
*

These factors do not directly influence the study outcomes (i.e., muscle decline), but may significantly affect the conduction of the study